Literature DB >> 23921863

Risk factors for urinary, fecal, or dual incontinence in the Nurses' Health Study.

Catherine A Matthews1, William E Whitehead, Mary K Townsend, Francine Grodstein.   

Abstract

OBJECTIVE: To estimate the prevalence of urinary incontinence, fecal incontinence, and dual incontinence in a large cohort of older women and compare risk factors across the three conditions.
METHODS: These cross-sectional analyses used data from the Nurses' Health Study. The 2008 questionnaire, mailed to 96,480 surviving participants aged 62-87 years, included two separate items on the prevalence of urinary and fecal incontinence. A response of leakage at least once per month defined incontinence for both urine and stool. Dual incontinence was defined by responses at this frequency for both conditions. Using a polytomous logistic regression model, we assessed each risk factor for prevalence of urinary, fecal, and dual incontinence.
RESULTS: The survey was completed by 64,396 women. Thirty-eight percent had urinary incontinence alone, 4% had fecal incontinence alone, and 7% had dual incontinence. Age older than 80 years compared with age younger than 70 years was associated most strongly with dual incontinence (odds ratio [OR] 2.49, 95% confidence interval [CI] 2.28-2.73) followed by depression (OR 2.28, 95% CI 2.13-2.43), neurologic disease (OR 1.84, 95% CI 1.65-2.07), functional limitations (OR 1.86, 95% CI 1.71-2.02), multiparity (OR 1.66, 95% CI 1.41-1.94), and heavier fetal birth weight (OR 1.24, 95% CI 1.10-1.41). Obesity was associated only with urinary incontinence (OR 1.99, 95% CI 1.90-2.08) and type 2 diabetes mellitus was a stronger risk factor for fecal than urinary incontinence (OR 1.43, 95% CI 1.28-1.59). Black race was associated with a reduced risk of all types of incontinence, especially dual incontinence (OR 0.30, 95% CI 0.21-0.44).
CONCLUSION: In this large cohort, dual incontinence was primarily associated with advanced age, decompensating medical conditions, depression, and multiparity. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2013        PMID: 23921863      PMCID: PMC3952631          DOI: 10.1097/AOG.0b013e31829efbff

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  28 in total

1.  Incidence and risk factors for fecal incontinence in black and white older adults: a population-based study.

Authors:  Alayne D Markland; Patricia S Goode; Kathryn L Burgio; David T Redden; Holly E Richter; Patricia Sawyer; Richard M Allman
Journal:  J Am Geriatr Soc       Date:  2010-06-01       Impact factor: 5.562

Review 2.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

3.  Risk factors for fecal incontinence: a population-based study in women.

Authors:  Adil E Bharucha; Alan R Zinsmeister; G Richard Locke; Barbara M Seide; Kimberly McKeon; Cathy D Schleck; L Joseph Melton
Journal:  Am J Gastroenterol       Date:  2006-06       Impact factor: 10.864

4.  Fecal incontinence in US women: a population-based study.

Authors:  Jennifer L Melville; Ming-Yu Fan; Katherine Newton; Dee Fenner
Journal:  Am J Obstet Gynecol       Date:  2005-12       Impact factor: 8.661

5.  Urinary incontinence, fecal incontinence and pelvic organ prolapse in a population-based, racially diverse cohort: prevalence and risk factors.

Authors:  Guri Rortveit; Leslee L Subak; David H Thom; Jennifer M Creasman; Eric Vittinghoff; Stephen K Van Den Eeden; Jeanette S Brown
Journal:  Female Pelvic Med Reconstr Surg       Date:  2010-09       Impact factor: 2.091

6.  Factors associated with symptom severity in women presenting with fecal incontinence.

Authors:  S B Menees; T M Smith; X Xu; W D Chey; R J Saad; D E Fenner
Journal:  Dis Colon Rectum       Date:  2013-01       Impact factor: 4.585

7.  The functional and psychosocial impact of fecal incontinence on women with urinary incontinence.

Authors:  M F Fialkow; J L Melville; G M Lentz; E A Miller; J Miller; D E Fenner
Journal:  Am J Obstet Gynecol       Date:  2003-07       Impact factor: 8.661

8.  Prevalence of double incontinence, risks and influence on quality of life in a general female population.

Authors:  Marijke C Ph Slieker-ten Hove; Annelies L Pool-Goudzwaard; Marinus J C Eijkemans; Regine P M Steegers-Theunissen; Curt W Burger; Mark E Vierhout
Journal:  Neurourol Urodyn       Date:  2010-04       Impact factor: 2.696

9.  Prevalence of urinary, fecal and double incontinence in the elderly living at home.

Authors:  T A M Teunissen; W J H M van den Bosch; H J M van den Hoogen; A L M Lagro-Janssen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-11-27

10.  Fecal incontinence in US adults: epidemiology and risk factors.

Authors:  William E Whitehead; Lori Borrud; Patricia S Goode; Susan Meikle; Elizabeth R Mueller; Ashok Tuteja; Alison Weidner; Milena Weinstein; Wen Ye
Journal:  Gastroenterology       Date:  2009-05-04       Impact factor: 22.682

View more
  26 in total

1.  Prevalence of and Factors Associated With Fecal Incontinence: Results From a Population-Based Survey.

Authors:  Stacy B Menees; Christopher V Almario; Brennan M R Spiegel; William D Chey
Journal:  Gastroenterology       Date:  2018-02-03       Impact factor: 22.682

2.  Overactive Bladder Is Strongly Associated With Frailty in Older Individuals.

Authors:  Anne M Suskind; Kathryn Quanstrom; Shoujun Zhao; Mark Bridge; Louise C Walter; John Neuhaus; Emily Finlayson
Journal:  Urology       Date:  2017-05-11       Impact factor: 2.649

3.  Factors associated with fecal incontinence in a nationally representative sample of diabetic women.

Authors:  Maria De La Luz Nieto; Jennifer M Wu; Catherine Matthews; William E Whitehead; Alayne D Markland
Journal:  Int Urogynecol J       Date:  2015-05-14       Impact factor: 2.894

4.  Female double incontinence: prevalence, incidence, and risk factors from the SABE (Health, Wellbeing and Aging) study.

Authors:  Denise R Yuaso; Jair L F Santos; Rodrigo A Castro; Yeda A O Duarte; Manoel J B C Girão; Bary Berghmans; José Tadeu N Tamanini
Journal:  Int Urogynecol J       Date:  2017-06-15       Impact factor: 2.894

5.  Urinary, fecal, and dual incontinence in older U.S. Adults.

Authors:  Jennifer M Wu; Catherine A Matthews; Camille P Vaughan; Alayne D Markland
Journal:  J Am Geriatr Soc       Date:  2015-05-04       Impact factor: 5.562

6.  Life Space Assessment in Older Women Undergoing Non-Surgical Treatment for Urinary Incontinence.

Authors:  Thomas L Wheeler; Jana D Illston; Alayne D Markland; Patricia S Goode; Holly E Richter
Journal:  Open J Obstet Gynecol       Date:  2014-10

7.  Epidemiology, pathophysiology, and classification of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop.

Authors:  Adil E Bharucha; Gena Dunivan; Patricia S Goode; Emily S Lukacz; Alayne D Markland; Catherine A Matthews; Louise Mott; Rebecca G Rogers; Alan R Zinsmeister; William E Whitehead; Satish S C Rao; Frank A Hamilton
Journal:  Am J Gastroenterol       Date:  2014-12-23       Impact factor: 10.864

8.  Written versus oral disclosure of fecal and urinary incontinence in women with dual incontinence.

Authors:  Sara B Cichowski; Yuko M Komesu; Gena C Dunivan; Clifford Qualls; Rebecca G Rogers
Journal:  Int Urogynecol J       Date:  2014-05-08       Impact factor: 2.894

Review 9.  Epidemiological trends and future care needs for pelvic floor disorders.

Authors:  Alexis A Dieter; Maggie F Wilkins; Jennifer M Wu
Journal:  Curr Opin Obstet Gynecol       Date:  2015-10       Impact factor: 1.927

10.  Functional Anorectal Disorders.

Authors:  Satish Sc Rao; Adil E Bharucha; Giuseppe Chiarioni; Richelle Felt-Bersma; Charles Knowles; Allison Malcolm; Arnold Wald
Journal:  Gastroenterology       Date:  2016-03-25       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.